Bridging from paediatric to young adults –best treatment approach
Non Hodgkin lymphoma in adolescents and young adults

https://doi.org/10.1016/S1359-6349(07)70043-5Get rights and content

First page preview

First page preview
Click to open first page preview
View PDF

References (40)

  • R Suzuki et al.

    Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype

    Blood

    (2000)
  • M Massimino et al.

    Ki-1 (CD30) anaplastic large-cell lymphoma in children

    Ann Oncol

    (1995)
  • Bleyer A, O'Leary M, Barr R, Ries LAG, eds. Cancer epidemiology in older adolescents and young adults 15 to 29 years of...
  • A Bleyer et al.

    Cancer in 15- to 29-year-olds by primary site

    Oncologist

    (2006)
  • MA Shipp et al.

    Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

    Nat Med

    (2002)
  • K Seideman et al.

    Short pulse B-non-Hodkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplstic large-cell lymphoma: a report of the Berlin-Frankfurt-Munster group trial NHL-BFM90

    Blood

    (2001)
  • F Montravers et al.

    [(18)F]-FDG in childhood lymphoma: clinical utility and impact on management

    Eur J Nucl Med Mol Imaging

    (2002)
  • S Barrington et al.

    Limitations of PET for imaging lymphoma

    Eur J Nucl Med Mol Imaging

    (2003)
  • R Pinkerton

    Continuing challenges in childhood non-Hodgkin's lymphoma

    Br J Haematol

    (2005)
    • View full text
    Copyright © 2007 Elsevier Ltd. All rights reserved.